# Medicare Part D Analysis Dashboard
> An Interactive Streamlit Dashboard for analyzing Medicare Part D prescription and cost data.

---

## ğŸ¯ Objective
This project analyzes Medicare Part D prescription data to:
- Identify the top prescribed generic and brand-name drugs.
- Highlight the top cost contributors.
- Evaluate the relationship between claim counts and total cost.
- Support actionable insights for stakeholders.

---

## âš¡ï¸ Features
- âœ… Interactive KPI metrics for total claims, total cost, top claimed generic, and top costly generic.
- âœ… Visual breakdown of top generic and brand-name drugs by claim counts.
- âœ… Bar chart of top generic drugs by total cost.
- âœ… Correlation analysis between total claim counts and total cost.
- âœ… Exportable and actionable results for stakeholders.

---

## ğŸ“ˆ Results & Insights
âœ… Generic medications dominate total claim counts.  
âœ… A handful of expensive medications drive overall cost.  
âœ… Lowâ€“moderate correlation (~0.25) suggests cost is not always directly tied to usage volume.

---

## ğŸ–¥ï¸ Screenshots
### KPIs
![Screenshot A](Images/KPIs.png)

### Top Generic Drugs by Claims
![Screenshot B](Images/Bar_chart_for_top_5_generic_claim_counts.png)

### Top Brand Name Drugs by Claims
![Screenshot C](Images/Bar_chart_for_top_5_generic_claim_counts.png)

### Top Generic Drugs by Cost
![Screenshot D](Images/Bar_chart_for_top_5_generic_drugs_by_cost.png)

### Correlation Metric and Commentary
![Screenshot E](Images/Correlation_metric_and_commentary.png)

---

## ğŸ’» Getting Started

### âœ… Prerequisites
Make sure you have **Python 3.9+** installed.

### âš¡ï¸ Install Dependencies
```bash
pip install -r requirements.txt
```

### ğŸš€ Run the Streamlit App
```bash
streamlit run app.py
```

---

## ğŸ”® Future Improvements
- Incorporate regional and patient-level analytics.
- Evaluate clinical outcomes associated with high-cost medications.
- Identify opportunities for cost optimization and targeted negotiations.

---

## âš–ï¸ License
This project is licensed under the MIT License.
